STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLGN
  4. [EFFECT] CollPlant Biotechnologies Ltd SEC Filing

[EFFECT] CollPlant Biotechnologies Ltd SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 16, 2026 4:30 P.M.
Form: F-3
CIK: 0001631487
Company Name: CollPlant Biotechnologies Ltd
File Number: 333-292640

Source: View Original Filing on SEC EDGAR

Collplant Biotechnologies Ltd

NASDAQ:CLGN

View CLGN Stock Overview →

CLGN Rankings

#6494 Ranked by Market Cap
N/A Ranked by Dividends

CLGN Latest News

Feb 26, 2026
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
Feb 23, 2026
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
Feb 17, 2026
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
Feb 5, 2026
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
Nov 26, 2025
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

CLGN Latest SEC Filings

Feb 26, 2026
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)
Feb 23, 2026
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)
Feb 17, 2026
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)
Feb 6, 2026
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)
Feb 6, 2026
[424B5] CollPlant Biotechnologies Ltd Prospectus Supplement (Debt Securities)

CLGN Stock Data

8.07M
8.97M
Biotechnology
Healthcare
Link
Israel
Rehovot